MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Annals of Hematology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

159 results · 1 filter active ·
Results by year
20012025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
159 works in the cohort · of 4,299,418page 2 of 4

Labels cover 0 of 159 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 159 of 159 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
Grzegorz S. Nowakowski, Dok Hyun Yoon, Patrizia Mondello, Erel Joffe, Anthea Peters, Isabelle Fleury +14 more
2023· article· en· Annals of Hematology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
21
citations
affno abstractunlabeled
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC
Amandine Le Bourgeois, Myriam Labopin, Ambroise Marçais, Régis Peffault de Latour, Didier Blaise, Sylvain Chantepie +15 more
2020· article· en· Annals of Hematology· Medicine
distilled prediction:candidate · noneconsensus · none
19
citations
affaboutno abstractunlabeled
Amyloidosis and COVID-19: experience from an amyloid program in Canada
Ellen M. Lewis, Nowell M. Fine, Robert J.H. Miller, Christopher Hahn, Sameer Chhibber, Etienne Mahé +6 more
2022· article· en· Annals of Hematology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
16
citations
affno abstractunlabeled
Successful treatment of Kimura disease with benralizumab
Vivian G. Szeto, Benjamin Chin‐Yee, Mina Dehghani, Kamilia Rizkalla, Christopher Licskai, Cyrus C. Hsia
2022· letter· en· Annals of Hematology· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
16
citations
affno abstractunlabeled
Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML
Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, Sung‐Hoon Jung, Deok‐Hwan Yang, Je‐Jung Lee +10 more
2015· article· en· Annals of Hematology· Medicine
distilled prediction:candidate · noneconsensus · none
15
citations
affno abstractunlabeled
Serum ferritin concentrations in Africans with low dietary iron
Victor Moyo, Elisha Mvundura, Hlosukwazi Khumalo, Innocent T. Gangaidzo, Thokozile Saungweme, Mehdi Nouraie +3 more
2009· article· en· Annals of Hematology· Medicine
distilled prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria
Hubert Schrezenmeier, Austin Kulasekararaj, Lindsay Mitchell, Régis Peffault de Latour, Timothy Devos, Shinichiro Okamoto +7 more
2023· article· en· Annals of Hematology· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
8
citations
affno abstractunlabeled
Cytarabine toxicity of the corneal endothelium
Hatem Krema, Ronaldo Santiago, Andre C. Schuh, Charles J. Pavlin
2012· letter· en· Annals of Hematology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
7
citations
← previousnext →

How this was built: Screen · Findings · About